In today’s recent session, 0.57 million shares of the TNF Pharmaceuticals Inc (NASDAQ:TNFA) have been traded, and its beta is 2.18. Most recently the company’s share price was $1.49, and it changed around $0.08 or 5.67% from the last close, which brings the market valuation of the company to $4.10M. TNFA at last check was trading at a discount to its 52-week high of $10.66, offering almost -615.44% off that amount. The share price’s 52-week low was $1.07, which indicates that the recent value has risen by an impressive 28.19% since then. We note from TNF Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 0.14 million shares, with the 3-month average coming to 52.98K.

TNF Pharmaceuticals Inc (NASDAQ:TNFA) trade information

Instantly TNFA has been showing a green trend so far today with a performance of 5.67% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.6380 on recent trading dayincreased the stock’s daily price by 9.04%. The company’s shares are currently down -80.80% year-to-date, but still up 31.36% over the last five days. On the other hand, TNF Pharmaceuticals Inc (NASDAQ:TNFA) is 11.19% up in the 30-day period. We can see from the shorts that 0.27 million shares have been sold at a short interest cover period of 6.39 day(s).

TNF Pharmaceuticals Inc (NASDAQ:TNFA)’s Major holders

Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024. The former held 13.69 shares worth $20529.0, making up 0.50% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 11.43 shares worth around $17135.0, which represents about 0.41% of the total shares outstanding.